2ESSB 5594 Details
| Legal Title | AN ACT Relating to reducing prescription drug costs by eliminating barriers impeding access to biosimilar medicines and interchangeable biological products; |
| Bill Description | Concerning biosimilar medicines. (REVISED FOR ENGROSSED: Concerning biosimilar medicines and interchangeable biological products.) |
Details
Bill Topics
Committee Hearings
| Hearing | Senate Health & Long-Term Care (Public) |
| Hearing | Senate Health & Long-Term Care (Executive) |
| Hearing | House Health Care & Wellness (Public) |
| Hearing | House Health Care & Wellness (Public) |
2ESSB 5594 Bill Timeline
Go to 2ESSB 5594 at leg.wa.gov
Strong Momentum
01/21/2026
Returned to second reading for amendment.
01/21/2026
Rules suspended.
01/19/2026
Placed on third reading.
01/19/2026
Rules Committee relieved of further consideration.
01/12/2026
By resolution, reintroduced and retained in present status.
04/27/2025
By resolution, returned to Senate Rules Committee for third reading.
03/13/2025
First reading, referred to Health Care & Wellness.
03/11/2025
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
03/11/2025
Rules suspended. Placed on Third Reading.
03/11/2025
Floor amendment(s) adopted.
03/11/2025
1st substitute bill substituted.
03/05/2025
Placed on second reading by Rules Committee.
02/19/2025
Passed to Rules Committee for second reading.
02/18/2025
HLTC - Majority; 1st substitute bill be substituted, do pass.
01/30/2025
First reading, referred to Health & Long-Term Care.